A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia
Clinical trial NCT02973191 · WITHDRAWN
Trial details
- NCT number
- NCT02973191
- Sponsor
- Celgene
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2019-06-25
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.